share_log

Scale Biosciences And Revvity's BioLegend Launch Solution For High Parameter Protein Profiling Of Single Cells; The TotalSeq Phenocyte Solution Supports Robust Study Of Cellular Heterogeneity And Rare Cell Types In Complex Samples At A Single Cell Level

Scale Biosciences And Revvity's BioLegend Launch Solution For High Parameter Protein Profiling Of Single Cells; The TotalSeq Phenocyte Solution Supports Robust Study Of Cellular Heterogeneity And Rare Cell Types In Complex Samples At A Single Cell Level

Scale Biosciences與Revvity的BioLegend聯合推出單細胞高參數蛋白質分析解決方案;TotalSeq表型解決方案支持在單細胞水平對複雜樣本中的細胞異質性和稀有細胞類型進行深入研究。
Benzinga ·  11/19 21:07

The TotalSeq Phenocyte solution supports robust study of cellular heterogeneity and rare cell types in complex samples at a single cell level

TotalSeq Phenocyte解決方案支持在單個電芯水平上對複雜樣本中的細胞異質性和稀有細胞類型進行深入研究

Scale Biosciences (Scale BioTM), a leader in innovative and scalable single cell analysis solutions, and Revvity's (NYSE:RVTY) BioLegend business, a leading provider of world-class biological reagents and tools, today announced the availability of a new, first-of-its-kind TotalSeqTM PhenocyteTM single-cell protein profiling solution that supports customers by more easily identifying and characterizing rare cell subtypes, which ultimately powers immunology and oncology research. The solution is enabled by the proprietary combination of Scale Biosciences' Quantum Barcoding technology platform and BioLegend's TotalSeqTM antibody conjugates.

Scale Biosciences(Scale BioTM),創新和可擴展單電芯分析解決方案的領導者,以及Revvity的(紐交所:RVTY)BioLegend業務,全球頂級生物試劑和工具的領先供應商,今天宣佈推出一種新型的、首創的TotalSeqTm PhenocyteTm單電芯蛋白質譜分析解決方案,該解決方案通過更輕鬆地識別和表徵稀有細胞亞型,爲客戶提供支持,從而推動免疫學和腫瘤學研究。該解決方案是由Scale Biosciences的Quantum Barcoding科技平台與BioLegend的TotalSeqTm抗體結合物的專有組合所推動的。

While technologies like mass cytometry and high-parameter flow cytometry enable protein analysis at the single cell level, these approaches require complex panel optimization and sophisticated instrumentation that limit their accessibility and scalability across multiple samples.

雖然像質譜細胞術和高參數流式細胞術等科技能夠在單電芯水平上進行蛋白質分析,但這些方法需要複雜的面板優化和精密的儀器,限制了其在多個樣本中的可接入性和可擴展性。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論